Russell Steven Jon 4
4 · Beta Bionics, Inc. · Filed Jun 4, 2025
Insider Transaction Report
Form 4
Russell Steven Jon
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-06-02$17.03/sh−285$4,853→ 72,786 total - Sale
Common Stock
2025-06-02$18.15/sh−660$11,978→ 72,126 total - Sale
Common Stock
2025-06-02$18.69/sh−94$1,757→ 72,032 total
Footnotes (4)
- [F1]The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- [F2]The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F4]The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.